Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)

Volume

51

Pagination

S720 - S720

DOI

10.1016/S0959-8049(16)31942-6

ISSN

0959-8049

Metadata

Show full item record

Authors

Rosenberg, J; Petrylak, D; Abidoye, O; Van der Heijden, MS; Hofman-Censits, J; Necchi, A; O'Donnell, PH; Balmanoukian, A; Loriot, Y; Retz, M

URI

http://qmro.qmul.ac.uk/xmlui/handle/123456789/11009

Collections

Centre for Experimental Cancer Medicine [111]

Licence information

doi:10.1016/S0959-8049(15)30074-5